Systematic Review and Meta-Analysis of Cisplatin Based Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer [0.03%]
肌 invasive 膀胱癌患者新辅助化疗中顺铂系统性回顾和荟萃分析
Raed Benkhadra,Tarek Nayfeh,Sai Krishna Patibandla et al.
Raed Benkhadra et al.
Background: Cisplatin-based neoadjuvant chemotherapy is the standard of care for muscle invasive bladder cancer (MIBC). Objective: To c...
Sensitivity and Specificity in Urine Bladder Cancer Markers - Is it that Simple? [0.03%]
敏感性和特异性在尿路上皮肿瘤标志物中的评价简单吗？
Florian Roghmann,Peter J Goebell,Lars Dyrskjøt et al.
Florian Roghmann et al.
Marker research, and in particular urine bladder cancer marker research throughout the past three decades, devours enormous scientific resources in terms of manpower (not to mention time spent on reviewing and editorial efforts) and financi...
Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial Carcinoma [0.03%]
局部晚期或转移性尿路上皮癌患者疼痛的定性分析
Susan Martin,Sonali N Shah,Zsolt Hepp et al.
Susan Martin et al.
Background: Pain is not well described in patients with locally advanced or metastatic urothelial cancer (la/mUC). Objective: To charac...
Prospective Evaluation of FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder Cancer [0.03%]
前瞻性评估FDG-PET/CT在侵袭性膀胱癌新辅助或诱导化疗疗效评价中的价值
Sarah M H Einerhand,Charlotte S Voskuilen,Elies E Fransen van de Putte et al.
Sarah M H Einerhand et al.
Background: Neoadjuvant/induction chemotherapy (NAIC) improves survival in patients with muscle-invasive bladder carcinoma (MIBC). On-treatment response assessment may aid in decisions to continue or cease NAIC. ...
Economic Outcomes of Hexaminolevulinate Blue-Light Cystoscopy in Non-Muscle Invasive Bladder Cancer: A 5-Year, Medicare-Based Model [0.03%]
基于 Medicare 的 5 年模型评估光敏膀胱镜检查在非肌层浸润性膀胱癌中的经济学效果
Michael L Creswell,Tamir N Sholklapper,Michael J Markel et al.
Michael L Creswell et al.
Background: Bladder cancer is the most expensive cancer to treat on a per-patient basis. Blue light cystoscopy with hexaminolevulinate (BLC) has demonstrated improved diagnostic accuracy compared with white light cystosco...
Mark S Soloway,Neil A Abrahams
Mark S Soloway
The Role of Local Agents for the Treatment of Localized Upper Tract Urothelial Carcinoma: A Review of the Current Evidence [0.03%]
局部上尿路尿路上皮癌治疗中局部分子标志物的作用：现有证据综述
Anastasios D Asimakopoulos,Maxim Kochergin,Christian Klöcker et al.
Anastasios D Asimakopoulos et al.
Kidney-sparing surgery (KSS) for upper urinary tract urothelial carcinoma (UTUC) is a promising alternative to radical nephroureterectomy, especially for low-risk cases. However, due to the established risk of ipsilateral UTUC recurrence ca...
An Association Study of Germline Variants in Bladder Cancer-Related Genes with the Prognosis of Non-Muscle Invasive Bladder Cancer [0.03%]
膀胱癌相关基因 germline变异与非肌层浸润性膀胱癌预后关系的队列研究
Jasper P Hof,Sita H Vermeulen,Antoine G van der Heijden et al.
Jasper P Hof et al.
Background: Various germline genetic variants are associated with the prognosis of non-muscle invasive bladder cancer (NMIBC). Germline variants in genes frequently somatically mutated in bladder cancer have not been stud...
Recent Advances in the Classification of Bladder Cancer - Updates from the 5th Edition of the World Health Organization Classification of the Urinary and Male Genital Tumors [0.03%]
WHO泌尿和男性生殖道肿瘤分类（第5版）中的膀胱癌分型进展
Charles C Guo,Steven S Shen,Bogdan Czerniak
Charles C Guo
Background: The World Health Organization Classification (WHO) of Urinary and Male Genital Tumors has recently been updated to its 5th edition. The new edition presents a comprehensive approach to the classification of ur...